Lipid profile parameters with body fat · Do the lipid profiles of Type 2 Diabetes Mellitus...

1
Do the lipid profiles of Type 2 Diabetes Mellitus patients and controls differ based on their body fat percentage and visceral fat levels? Gayathri Rathnayake 1 , Rasika Perera 1 , Usha Hettiaratchi 1 1 Department of Biochemistry, Faculty of Medical Sciences, University of Sri Jayewardenepura, Colombo, Sri Lanka. Introduction Introduction Body fat percentage (BF%) including both the visceral and subcutaneous levels of an individual is posively associated with hypertension, dyslipidemia, diabetes and coronary heart disease (1,2) . Analysis of BF% using Bio Impedance Analyzer (BIA) is the most convenient, relavely simple, quick and non-invasive method when populaon based studies are concerned. objectives objectives Aim of this study was to determine whether the lipid profiles of female Type 2 Diabetes Mellitus (T2DM) paents and controls differ based on their risk and non risk BF% and visceral fat levels. Methods Methods T2DM paents and non-diabec (each n=24) females living in North Cen- tral province of Sri Lanka were selected using convenient sampling meth- od. Ten and twelve hour fasng blood samples were collected for determina- on of fasng blood sugar (FBS) and lipid profile assays *total cholesterol (TC), serum triglyceride (TG), high density lipoprotein (HDL) cholesterol+ using standard kits. low density lipoprotein (LDL) cholesterol levels were determined using the freidwald equaon BF% and visceral fat level were determined using BIA (OMRON HBF-362) analyzer. BF% 30 was considered as obese and visceral fat level 9 con- sidered as the risk level (manufacturer’s cut off data). Results Results FBS levels of T2DM group and control group were 129.9 mg/dl, 82.9 mg/ dl respecvely and were significantly different (p<0.05). However, the lipid profile values were not significantly different between two groups except for TG level (p=<0.05). Among cases and controls hypercholesterolemia, hypertriglyceridemia, reduced HDL levels and increased LDL levels were presented in 33.3%, 33.5%, 45.8%, 29.2% of cases and 37.5%, 42.0%, 16.7%, 41.7% of controls whose BF% were 30% respecvely. However, none of the lipid parameters were significantly different among the two groups. When visceral fat levels were concerned hypercholesterolemia, reduced HDL levels and increased LDL levels were presented in equal percentage of cases (8.3%) as well as controls (8.3%) for all these three parameters whose visceral fat level is 9. None of the cases or controls with visceral fat levels 9 was having hy- pertriglyceridemia indicang that the risk cut off value suggested by the manufacturer for the visceral fat level may not be opmum to deduce the risk for the current populaon. Conclusions Conclusions As the groups with BF% 30 or visceral fat levels ≥ 9 did not show any sig- nificant differences in lipid parameters compared with the non risk groups among these T2DM paents and controls, studies are currently being carried out with a larger sample size to understand whether the body fat levels associate with dyslipidemia regardless of having diabetes. Digital display Digital display output of the output of the Bio Impedance Bio Impedance analyzer analyzer Body fat Body fat level level measureme measureme nt using Bio nt using Bio impedance impedance analysis analysis method method References References 1. Smith SR, Lovejoy JC, Greenway F, Ryan D, de la Bretonne J, Volafova J, Bray GA. Contribuons of total body fat, abdominal subcutaneous adipose ssue compartments, and visceral adipose ssue to the metabolic complicaons of obesity. Metab- olism. 2001 Apr 30;50(4):425-35. 2. Vega GL, Adams-Huet B, Peshock R, Wille D, Shah B, Grundy SM. Influence of body fat content and distribuon on varia- on in metabolic risk. The Journal of Clinical Endocrinology & Metabolism. 2006 Nov;91(11):4459-66. 0 5 10 15 20 25 30 35 Lipid profile parameters and visceral fat level Body fat <30% Body fat ≥ 30% 0 5 10 15 20 25 30 35 Lipid profile parameters with body fat percentage visceral fat <9 Viscral fat ≥9

Transcript of Lipid profile parameters with body fat · Do the lipid profiles of Type 2 Diabetes Mellitus...

Page 1: Lipid profile parameters with body fat · Do the lipid profiles of Type 2 Diabetes Mellitus patients and controls differ based on their body fat percentage and visceral fat levels?

Do the lipid profiles of Type 2 Diabetes Mellitus patients and controls differ based on

their body fat percentage and visceral fat levels?

Gayathri Rathnayake1, Rasika Perera

1, Usha Hettiaratchi

1

1Department of Biochemistry, Faculty of Medical Sciences, University of Sri Jayewardenepura, Colombo, Sri Lanka.

IntroductionIntroduction

Body fat percentage (BF%) including both the visceral and subcutaneous

levels of an individual is positively associated with hypertension,

dyslipidemia, diabetes and coronary heart disease (1,2) . Analysis of BF%

using Bio Impedance Analyzer (BIA) is the most convenient, relatively

simple, quick and non-invasive method when population based studies

are concerned.

objectivesobjectives

Aim of this study was to determine whether the lipid profiles of female

Type 2 Diabetes Mellitus (T2DM) patients and controls differ based on

their risk and non risk BF% and visceral fat levels.

MethodsMethods

T2DM patients and non-diabetic (each n=24) females living in North Cen-

tral province of Sri Lanka were selected using convenient sampling meth-

od.

Ten and twelve hour fasting blood samples were collected for determina-

tion of fasting blood sugar (FBS) and lipid profile assays *total cholesterol

(TC), serum triglyceride (TG), high density lipoprotein (HDL) cholesterol+

using standard kits.

low density lipoprotein (LDL) cholesterol levels were determined using

the freidwald equation

BF% and visceral fat level were determined using BIA (OMRON HBF-362)

analyzer. BF% ≥30 was considered as obese and visceral fat level ≥9 con-

sidered as the risk level (manufacturer’s cut off data).

ResultsResults

FBS levels of T2DM group and control group were 129.9 mg/dl, 82.9 mg/

dl respectively and were significantly different (p<0.05).

However, the lipid profile values were not significantly different between

two groups except for TG level (p=<0.05).

Among cases and controls hypercholesterolemia, hypertriglyceridemia,

reduced HDL levels and increased LDL levels were presented in 33.3%,

33.5%, 45.8%, 29.2% of cases and 37.5%, 42.0%, 16.7%, 41.7% of controls

whose BF% were ≥ 30% respectively.

However, none of the lipid parameters were significantly different among

the two groups.

When visceral fat levels were concerned hypercholesterolemia, reduced

HDL levels and increased LDL levels were presented in equal percentage

of cases (8.3%) as well as controls (8.3%) for all these three parameters

whose visceral fat level is ≥ 9.

None of the cases or controls with visceral fat levels ≥ 9 was having hy-

pertriglyceridemia indicating that the risk cut off value suggested by the

manufacturer for the visceral fat level may not be optimum to deduce

the risk for the current population.

ConclusionsConclusions

As the groups with BF% ≥30 or visceral fat levels ≥ 9 did not show any sig-

nificant differences in lipid parameters compared with the non risk

groups among these T2DM patients and controls, studies are currently

being carried out with a larger sample size to understand whether the

body fat levels associate with dyslipidemia regardless of having diabetes.

Digital display Digital display

output of the output of the

Bio Impedance Bio Impedance

analyzeranalyzer

Body fat Body fat

level level

measurememeasureme

nt using Bio nt using Bio

impedance impedance

analysis analysis

methodmethod

References References 1. Smith SR, Lovejoy JC, Greenway F, Ryan D, de la Bretonne J, Volafova J, Bray GA. Contributions of total body fat, abdominal

subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metab-

olism. 2001 Apr 30;50(4):425-35.

2. Vega GL, Adams-Huet B, Peshock R, Willett D, Shah B, Grundy SM. Influence of body fat content and distribution on varia-

tion in metabolic risk. The Journal of Clinical Endocrinology & Metabolism. 2006 Nov;91(11):4459-66.

0

5

10

15

20

25

30

35

Lipid profile parameters and visceral fat level

Body fat <30% Body fat ≥ 30%

0

5

10

15

20

25

30

35

Lipid profile parameters with body fat percentage

visceral fat <9 Viscral fat ≥9